ReSPECT-LM: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (clinicaltrials.gov) - Mar 26, 2025 - P1 | N=18 | Active, not recruiting | Sponsor: Plus Therapeutics | Recruiting ➔ Active, not recruiting
Enrollment closed • Oncology
|